Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells

Cellular and Molecular Immunology

Volumn 13, Issue 3, 2016, Pages 277-292

  Horst, Andrea Kristina ^a   Neumann, Katrin ^a   Diehl, Linda ^a   Tiegs, Gisa ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR9;

ALLOGRAFT; ANTIGEN PRESENTING CELL; APOPTOSIS; CARCINOGENESIS; CLONAL ANERGY; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER; LIVER CELL; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA; MODULATION; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PIG; REGULATORY T LYMPHOCYTE; REVIEW; SCHISTOSOMIASIS; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; ULTRASTRUCTURE;

ANIMALS; ANTIGEN-PRESENTING CELLS; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; LIVER; MODELS, BIOLOGICAL; T-LYMPHOCYTES, REGULATORY;

EID: 84966356820     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2015.112     Document Type: Review

References (201)

1. Tiegs G, Lohse AW. Immune tolerance: what is unique about the liver. J Autoimmun 2010; 34: 1-6.
2. Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 2010; 10: 753-766.
3. Gao B, Jeong WI, Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008; 47: 729-736.
4. Crispe IN. Immune tolerance in liver disease. Hepatology 2014; 60: 2109-2117.
5. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009; 27: 147-163.
6. Parker GA, Picut CA. Immune functioning in non lymphoid organs: the liver. Toxicol Pathol 2012; 40: 237-247.
7. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006; 43: S54-S62.
8. Di Marco R, Xiang M, Zaccone P, Leonardi C, Franco S, Meroni P et al. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. Autoimmunity 1999; 31: 75-83.
9. Erhardt A, Biburger M, Papadopoulos T, Tiegs G. regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007; 45: 475-485.
10. Heymann F, Hamesch K, Weiskirchen R, Tacke F. The concanavalin A model of acute hepatitis in mice. Lab Anim 2015; 49: 12-20.
11. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
12. Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol 2013; 14: 996-1006.
13. Callery MP, Kamei T, Flye MW. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res 1989; 46: 391-394.
14. Yang R, Liu Q, Grosfeld JL, Pescovitz MD. Intestinal venous drainage through the liver is a prerequisite for oral tolerance induction. J Pediatr Surg 1994; 29: 1145-1148.
15. Gorczynski RM, Chan Z, Fau-Chung S, Chung S, Fau-Cohen Z, Cohen Z et al. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage. Transplantation 1994; 58: 816-820.
16. Knolle PA, Limmer A. Control of immune responses by scavenger liver endothelial cells. Swiss Med Wkly 2003; 133: 501-506.
17. Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL et al. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest 1997; 99: 2782-2790.
18. Menezes GB, Lee WY, Zhou H, Waterhouse CC, Cara DC, Kubes P. Selective down-regulation of neutrophil Mac-1 in endotoxemic hepatic microcirculation via IL-10. J Immunol 2009; 183: 7557-7568.
19. McDonald B, McAvoy EF, Lam F, Gill V, de la Motte C, Savani RC et al. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med 2008; 205: 915-927.
20. McDonald B, Jenne CN, Zhuo L, Kimata K, Kubes P. Kupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemia. Am J Physiol Gastrointest Liver Physiol 2013; 305: G797-G806.
21. Wolf D, Schumann J, Koerber K, Kiemer AK, Vollmar AM, Sass G et al. Low-molecular-weight hyaluronic acid induces nuclear factor-kappaB-dependent resistance against tumor necrosis factor alpha-mediated liver injury in mice. Hepatology 2001; 34: 535-547.
22. John B, Crispe IN. TLR-4 regulates CD8+ T cell trapping in the liver. J Immunol 2005; 175: 1643-1650.
23. John B, Crispe IN. Passive and active mechanisms trap activated CD8+ T cells in the liver. J Immunol 2004; 172: 5222-5229.
24. Schurich A, Berg M, Stabenow D, Bottcher J, Kern M, Schild HJ et al. Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells. J Immunol 2010; 184: 4107-4114.
25. Smedsrod B, Le Couteur D, Ikejima K, Jaeschke H, Kawada N, Naito M et al. Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium. Liver Int 2009; 29: 490-501.
26. Tang L, Yang J, Liu W, Tang X, Chen J, Zhao D et al. Liver sinusoidal endothelial cell lectin, LSECtin, negatively regulates hepatic e5-cell immune response. Gastroenterology 2009; 137: 1498-1508. e5.
27. Knolle PA, Uhrig A, Hegenbarth S, Löser E, Schmitt E, Gerken G et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 1998; 114: 427-433.
28. Knolle PA, Germann T, Treichel U, Uhrig A, Schmitt E, HEgenbarth S et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol 1999; 162: 1401-1407.
29. Kruse N, Neumann K, Schrage A, Derkow K, Schott E, Erben U et al. Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3- regulatory T cells suppressing autoimmune hepatitis. Hepatology 2009; 50: 1904-1913.
30. Carambia A, Frenzel C, Bruns OT, Schwinge D, Reimer R, Hohenberg H et al. Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells. J Hepatol 2013; 58: 112-118.
31. Klugewitz K, Blumenthal-Barby F, Schrage A, Knolle PA, Hamann A, Crispe IN. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gammaproducing cells after intravenous protein immunization. J Immunol 2002; 169: 2407-2413.
32. Carambia A, Freund B, Schwinge D, Bruns OT, Salmen SC, Ittrich H et al. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice. J Hepatol 2015; 62: 1349-1356.
33. Neumann K, Rudolph C, Neumann C, Janke M, Amsen D, Scheffold A. Liver sinusoidal endothelial cells induce immunosuppressive IL-10-producing Th1 cells via the Notch pathway. Eur J Immunol 2015; 45: 2008-2016.
34. Morell CM, Strazzabosco M. Notch signaling and new therapeutic options in liver disease. J Hepatol 2014; 60: 885-890.
35. Geisler F, Strazzabosco M. Emerging roles of Notch signaling in liver disease. Hepatology 2015; 61: 382-392.
36. Neumann K, Kruse N, Szilagyi B, Erben U, Rudolph C, Flach A et al. Connecting liver and gut: murine liver sinusoidal endothelium induces gut tropism of CD4+ T cells via retinoic acid. Hepatology 2012; 55: 1976-1984.
37. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008; 181: 2277-2284.
38. Eksteen B, Grant AJ, Miles A, Curbishley SM, Lalor PF, Hubscher SG et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 2004; 200: 1511-1517.
39. Kunkel EJ, Campbell JJ, Haraldsen G, Pan J, Boisvert J, Roberts AI et al. Lymphocyte Cc chemokine receptor 9 and epithelial thymus-expressed chemokine (Teck) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J Exp Med 2000; 192: 761-768.
40. Bottcher JP, Schanz O, Wohlleber D, Abdullah Z, Debey-Pascher S, Staratschek-Jox A et al. Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity. Cell Rep 2013; 3: 779-795.
41. Heydtmann M, Hardie D, Shields PL, Faint J, Buckley CD, Campbell JJ et al. Detailed analysis of intrahepatic CD8 T cells in the normal and hepatitis C-infected liver reveals differences in specific populations of memory cells with distinct homing phenotypes. J Immunol 2006; 177: 729-738.
42. Diehl L, Schurich A, Grochtmann R, Hegenbarth S, Chen L, Knolle PA. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 2008; 47: 296-305.
43. Limmer A, Ohl J, Wingender G, Berg M, Jungerkes F, Schumak B et al. Cross-presentation of oral antigens by liver sinusoidal endothelial cells leads to CD8 T cell tolerance. Eur J Immunol 2005; 35: 2970-2981.
44. Limmer A, Ohl J, Kurts C, Ljunggren H-G, Reiss Y, Groetterup M et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results. Nat Med 2000; 6: 1348-1354.
45. Kaczmarek J, Homsi Y, van Uum J, Metzger C, Knolle PA, Kolanus W et al. Liver sinusoidal endothelial cell-mediated CD8 T cell priming depends on co-inhibitory signal integration over time. PLoS One 2014; 9: e99574.
46. Bottcher JP, Schanz O, Garbers C, Zaremba A, Hegenbarth S, Kurts C et al. IL-6 trans-signaling-dependent rapid development of cytotoxic CD8+ T cell function. Cell Rep 2014; 8: 1318-1327.
47. Wong YC, Tay SS, McCaughan GW, Bowen DG, Bertolino P. Immune outcomes in the liver: Is CD8 T cell fate determined by the environment? J Hepatol 2015; 63: 1005-1014.
48. Schildberg FA, Hegenbarth SI, Schumak B, Scholz K, Limmer A, Knolle PA. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur J Immunol 2008; 38: 957-967.
49. Schildberg FA, Wojtalla A, Siegmund SV, Endl E, Diehl L, Abdullah Z et al. Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism. Hepatology 2011; 54: 262-272.
50. Hutchins NA, Wang F, Wang Y, Chung CS, Ayala A. Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1. J Leukoc Biol 2013; 94: 963-970.
51. Eckert C, Klein N, Kornek M, Lukacs-Kornek V. The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation. Front Immunol 2015; 6: 179.
52. Ebe Y, Hasegawa G, Takatsuka H, Umezu H, Mitsuyama M, Arakawa M et al. The role of Kupffer cells and regulation of neutrophil migration into the liver by macrophage inflammatory protein-2 in primary listeriosis in mice. Pathol Int 1999; 49: 519-532.
53. Lee WY, Moriarty TJ, Wong CH, Zhou H, Strieter RM, van Rooijen N et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol 2010; 11: 295-302.
54. Helmy KY, Katschke Jr KJ, Gorgani NN, Kljavin NM, Elliott JM, Diehl L et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006; 124: 915-927.
55. Boermeester MA, Houdijk APJ, Myer S, Cuesta MA, Appelmelk BJ, Wesdorp RIC et al. Liver failure inudes a systemic inflammatory response. Am J Pathol 1995; 147: 1428-1440.
56. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-739.
57. Chensue SW, Terebuh PD, Rernick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Am J Pathol 1991; 138: 395-402.
58. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 1995; 22: 226-229.
59. You Q, Cheng L, Kedl RM, Ju C. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 2008; 48: 978-990.
60. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998; 160: 5729-5734.
61. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010; 11: 889-896.
62. Li X, Wang Z, Zou Y, Lu E, Duan J, Yang H et al. Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization. Immunol Res 2015; 62: 137-145.
63. Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 2014; 59: 130-142.
64. Heymann F, Peusquens J, Ludwig-Portugall I, Kohlhepp M, Ergen C, Niemietz P et al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology 2015; 62: 279-291.
65. Maemura K, Zheng Q, Wada T, Ozaki M, Takao S, Aikou T et al. Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells. Immunol Cell Biol 2005; 83: 336-343.
66. Wu K, Kryczek I, Chen L, Zou W, Welling TH. Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res 2009; 69: 8067-8075.
67. Oikawa T, Takahashi H, Ishikawa T, Hokari A, Otsuki N, Azuma M et al. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease. Pathol Int 2007; 57: 485-492.
68. Xie Z, Chen Y, Zhao S, Yang Z, Yao X, Guo S et al. Intrahepatic PD-1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection. Immunol Invest 2009; 38: 624-638.
69. Chen J, Wang XM, Wu XJ, Wang Y, Zhao H, Shen B et al. Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B. Inflamm Res 2011; 60: 47-53.
70. Dolina JS, Sung SS, Novobrantseva TI, Nguyen TM, Hahn YS. Lipidoid nanoparticles containing PD-L1 siRNA delivered in vivo enter Kupffer cells and enhance NK and CD8(+) T cell-mediated hepatic antiviral immunity. Mol Ther Nucleic Acids 2013; 2: e72.
71. Uchikura K, Wada T, Hoshino S, Nagakawa Y, Aiko T, Bulkley GB et al. Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species. Am J Physiol Gastrointest Liver Physiol 2004; 287: G620-G626.
72. Müschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R, Häussinger D. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology 1999; 116: 666-677.
73. Sun ZL, Wada T, Uchikura K, Ceppa E, Klein AS. Role of Fas/Fasl in Kupffer cell-dependent deletion of alloantigen activated T cells following liver transplantation. Transplant Proc 2001; 33: 279-282.
74. Sun Z, Wada T, Maemura K, Uchikura K, Hoshino S, Diehl AM et al. Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transpl 2003; 9: 489-497.
75. Tiegs G, Hentschel J, Wendel AA. T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.
76. Kunstle G, Hentze H, Germann PG, Tiegs G, Meergans T, Wendel A. Concanavalin A hepatotoxicity in mice: tumor necrosis factormediated organ failure independent of caspase-3-like protease activation. Hepatology 1999; 30: 1241-1251.
77. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Geiyo F et al. Augmentation of Va14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 2000; 191: 105-114.
78. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000; 97: 5498-5503.
79. Schümann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 2000; 157: 1671-1683.
80. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21: 190-198.
81. Kusters S, Gantner F, Kunstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996; 111: 462-471.
82. Nicoletti F, Di Marco R, Zaccone P, Salvaggio A, Magro G, Bendtzen K et al. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism. Hepatology 2000; 32: 728-733.
83. Matta BM, Castellaneta A, Thomson AW. Tolerogenic plasmacytoid DC. Eur J Immunol 2010; 40: 2667-2676.
84. Raich-Regue D, Glancy M, Thomson AW. Regulatory dendritic cell therapy: from rodents to clinical application. Immunol Lett 2014; 161: 216-221.
85. Lukacs-Kornek V, Schuppan D. Dendritic cells in liver injury and fibrosis: shortcomings and promises. J Hepatol 2013; 59: 1124-1126.
86. Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol 2012; 13: 888-899.
87. Tokita D, Mazariegos GV, Zahorchak AF, Chien N, Abe M, Raimondi G et al. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 2008; 85: 369-377.
88. Tokita D, Sumpter TL, Raimondi G, Zahorchak AF, Wang Z, Nakao A et al. Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J Hepatol 2008; 49: 1008-1018.
89. Castellaneta A, Sumpter TL, Chen L, Tokita D, Thomson AW. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J Immunol 2009; 183: 6922-6932.
90. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 2006; 7: 1250-1257.
91. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA 2008; 105: 10113-10118.
92. Chen X, Du Y, Huang Z. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity. Immunol Lett 2012; 148: 83-89.
93. Mikami Y, Mizuno S, Nakamoto N, Hayashi A, Sujino T, Sato T et al. Macrophages and dendritic cells emerge in the liver during intestinal inflammation and predispose the liver to inflammation. PLoS One 2014; 9: e84619.
94. Nakamoto N, Ebinuma H, Kanai T, Chu PS, Ono Y, Mikami Y et al. CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis. Gastroenterology 2012; 142: 366-376.
95. Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J, Butcher EC. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat Immunol 2008; 9: 1253-1260.
96. Ibrahim J, Nguyen AH, Rehman A, Ochi A, Jamal M, Graffeo CS et al. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology 2012; 143: 1061-1072.
97. Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 2002; 50: 571-581.
98. Baba S, Fujii H, Hirose T, Yasuchika K, Azuma H, Hoppo T et al. Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 2004; 40: 255-260.
99. Weiskirchen R, Tacke F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr 2014; 3: 344-363.
100. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008; 88: 125-172.
101. Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: concept to treatment. J Hepatol 2015; 62: S15-S24.
102. Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut 2015; 64: 830-841.
103. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007; 26: 117-129.
104. Winau F, Quack C, Darmoise A, Kaufmann SH. Starring stellate cells in liver immunology. Curr Opin Immunol 2008; 20: 68-74.
105. Ichikawa S, Mucida D, Tyznik AJ, Kronenberg M, Cheroutre H. Hepatic stellate cells function as regulatory bystanders. J Immunol 2011; 186: 5549-5555.
106. Dunham RM, Thapa M, Velazquez VM, Elrod EJ, Denning TL, Pulendran B et al. Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid. J Immunol 2013; 190: 2009-2016.
107. Yu MC, Chen CH, Liang X, Wang L, Gandhi CR, Fung JJ et al. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 2004; 40: 1312-1321.
108. Scholzel K, Schildberg FA, Welz M, Borner C, Geiger S, Kurts C et al. Transfer of MHC-class-I molecules among liver sinusoidal cells facilitates hepatic immune surveillance. J Hepatol 2014; 61: 600-608.
109. Davis DM. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat Rev Immunol 2007; 7: 238-243.
110. Dhainaut M, Moser M. Regulation of immune reactivity by intercellular transfer. Front Immunol 2014; 5: 112.
111. Carambia A, Herkel J. Liver sinusoidal cells collecting MHC-I molecules: you can't get enough of a good thing. J Hepatol 2014; 61: 464-465.
112. Arnold B. Parenchymal cells in immune and tolerance induction. Immunol Lett 2003; 89: 225-228.
113. Herkel J, Jagemann B, Wiegard C, Lazaro JF, Lueth S, Kanzler S et al. MHC class II-expressing hepatocytes function as antigenpresenting cells and activate specific CD4 T lymphocyutes. Hepatology 2003; 37: 1079-1085.
114. Bertolino P, Trescol-Biémont M-C, Rabourdin-Combe C. Hepatocytes induce functional activation of naiveCD8+T lymphocytes but fail to promote survival. Eur J Immunol 1998; 28: 221-236.
115. Tay SS, Wong YC, McDonald DM, Wood NA, Roediger B, Sierro F et al. Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses. Proc Natl Acad Sci USA 2014; 111: E2540-E2549.
116. Benseler V, Warren A, Vo M, Holz LE, Tay SS, Le Couteur DG et al. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci USA 2011; 108: 16735-16740.
117. Burghardt S, Erhardt A, Claass B, Huber S, Adler G, Jacobs T et al. Hepatocytes contribute to immune regulation in the liver by activation of the Notch signaling pathway in T cells. J Immunol 2013; 191: 5574-5582.
118. Burghardt S, Claass B, Erhardt A, Karimi K, Tiegs G. Hepatocytes induce Foxp3+ regulatory T cells by Notch signaling. J Leukoc Biol 2014; 96: 571-577.
119. Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F. Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology 1988; 8: 449-454.
120. Stross L, Gunther J, Gasteiger G, Asen T, Graf S, Aichler M et al. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology 2012; 56: 873-883.
121. Kido M, Watanabe N, Okazaki T, Akamatsu T, Tanaka J, Saga K et al. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology 2008; 135: 1333-1343.
122. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204: 1775-1785.
123. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204: 1757-1764.
124. Carambia A, Freund B, Schwinge D, Heine M, Laschtowitz A, Huber S et al. TGF-beta-dependent induction of CD4(+)CD25(+)Foxp3(+) Tregs by liver sinusoidal endothelial cells. J Hepatol 2014; 61: 594-599.
125. Luth S, Huber S, Schramm C, Buch T, Zander S, Stadelmann C et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigenspecific Tregs. J Clin Invest 2008; 118: 3403-3410.
126. Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW, Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 2006; 44: 1182-1190.
127. Menning A, Loddenkemper C, Westendorf AM, Szilagyi B, Buer J, Siewert C et al. Retinoic acid-induced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation. Eur J Immunol 2010; 40: 2539-2548.
128. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009; 10: 1178-1184.
129. Chen D, Bromberg JS. T regulatory cells and migration. Am J Transplant 2006; 6: 1518-1523.
130. Erhardt A, Wegscheid C, Claass B, Carambia A, Herkel J, Mittrucker HW et al. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis. J Immunol 2011; 186: 5284-5293.
131. Li W, Kuhr CS, Zheng XX, Carper K, Thomson AW, Reyes JD et al. New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells. Am J Transplant 2008; 8: 1639-1651.
132. Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol 2012; 57: 125-132.
133. Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Regulatory T cells in autoimmune hepatitis. J Hepatol 2012; 57: 932-933.
134. Kumar V. NKT-cell subsets: promoters and protectors in inflammatory liver disease. J Hepatol 2013; 59: 618-620.
135. Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 2011; 11: 131-142.
136. Park S-H, Weiss A, Benlagha K, Kyin T, Teyton L, Bendelac A. The mouse Cd1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med 2001; 193: 893-904.
137. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336.
138. Hickey MJ, Kubes P. Intravascular immunity: the host-pathogen encounter in blood vessels. Nat Rev Immunol 2009; 9: 364-375.
139. Zajonc DM, Girardi E. Recognition of microbial glycolipids by natural killer T cells. Front Immunol 2015; 6: 400.
140. Shimamura K, Kawamura H, Nagura T, Kato T, Naito T, Kameyama H et al. Association of NKT cells and granulocytes with liver injury after reperfusion of the portal vein. Cell Immunol 2005; 234: 31-38.
141. Arrenberg P, Maricic I, Kumar V. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. Gastroenterology 2011; 140: 646-655.
142. Deng ZB, Liu Y, Liu C, Xiang X, Wang J, Cheng Z et al. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 2009; 50: 1412-1420.
143. Syn WK, Agboola KM, Swiderska M, Michelotti GA, Liaskou E, Pang H et al. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 2012; 61: 1323-1329.
144. Mattner J. Natural killer T (NKT) cells in autoimmune hepatitis. Curr Opin Immunol 2013; 25: 697-703.
145. Wang H, Feng D, Park O, Yin S, Gao B. Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-gamma. Hepatology 2013; 58: 1474-1485.
146. Halder RC, Aguilera C, Maricic I, Kumar V. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest 2007; 117: 2302-2312.
147. Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009; 86: 513-528.
148. Maricic I, Girardi E, Zajonc DM, Kumar V. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease. J Immunol 2014; 193: 4580-4589.
149. Biburger M, Tiegs G. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. J Leukoc Biol 2008; 84: 264-279.
150. Eberl G, MacDonald HR. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000; 30: 985-992.
151. Santodomingo-Garzon T, Han J, Le T, Yang Y, Swain MG. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 2009; 49: 1267-1276.
152. Chen J, Wei Y, He J, Cui G, Zhu Y, Lu C et al. Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota. Sci Rep 2014; 4: 7259.
153. Yan S, Wang L, Liu N, Wang Y, Chu Y. Critical role of interleukin-17/ interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol Cell Biol 2012; 90: 421-428.
154. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007; 27: 647-659.
155. Korn T, Mitsdoerffer M, Croxford AL, Awasthi A, Dardalhon VA, Galileos G et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 2008; 105: 18460-18465.
156. Zhao N, Hao J, Ni Y, Luo W, Liang R, Cao G et al. Vgamma4 gammadelta T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J Immunol 2011; 187: 5007-5014.
157. Monteiro M, Almeida CF, Agua-Doce A, Graca L. Induced IL-17- producing invariant NKT cells require activation in presence of TGF-beta and IL-1beta. J Immunol 2013; 190: 805-811.
158. Wondimu Z, Santodomingo-Garzon T, Le T, Swain MG. Protective role of interleukin-17 in murine NKT cell-driven acute experimental hepatitis. Am J Pathol 2010; 177: 2334-2346.
159. Swain MG. Hepatic NKT cells: friend or foe? Clin Sci 2008; 114: 457-466.
160. La Cava A, Van Kaer L, Fu Dong S. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol 2006; 27: 322-327.
161. Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat Rev Immunol 2003; 3: 211-222.
162. Hammond KJ, Kronenberg M. Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr Opin Immunol 2003; 15: 683-689.
163. Jiang S, Game DS, Davies D, Lombardi G, Lechler RI. Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4 +CD25+ regulatory T cells? Eur J Immunol 2005; 35: 1193-1200.
164. Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells-how did we miss them? Nat Rev Immunol 2013; 13: 75-87.
165. Hazenberg MD, Spits H. Human innate lymphoid cells. Blood 2014; 124: 700-709.
166. Subleski JJ, Hall VL, Back TC, Ortaldo JR, Wiltrout RH. Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver. Cancer Res 2006; 66: 11005-11012.
167. Tian Z, Chen Y, Gao B. Natural killer cells in liver disease. Hepatology 2013; 57: 1654-1662.
168. Doherty DG. Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J Autoimmun 2015; 66: 60-75; pii: S0896-8411(15)30038-X.
169. Sun H, Sun C, Tian Z, Xiao W. NK cells in immunotolerant organs. Cell Mol Immunol 2013; 10: 202-212.
170. Krueger PD, Lassen MG, Qiao H, Hahn YS. Regulation of NK cell repertoire and function in the liver. Crit Rev Immunol 2011; 31: 43-52.
171. Lassen MG, Lukens JR, Dolina JS, Brown MG, Hahn YS. Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol 2010; 184: 2693-2701.
172. Tu Z, Bozorgzadeh A, Pierce RH, Kurtis J, Crispe IN, Orloff MS. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med 2008; 205: 233-244.
173. Notas G, Kisseleva T, Brenner D. NK and NKT cells in liver injury and fibrosis. Clin Immunol 2009; 130: 16-26.
174. Chong WP, Zhou J, Law HK, Tu W, Lau YL. Natural killer cells become tolerogenic after interaction with apoptotic cells. Eur J Immunol 2010; 40: 1718-1727.
175. Chen Y, Sun R, Jiang W, Wei H, Tian Z. Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner. J Hepatol 2007; 47: 183-190.
176. Muhlen KA, Schumann J, Wittke F, Stenger S, van Rooijen N, van Kaer L et al. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J Immunol 2004; 172: 3034-3041.
177. Wang J, Sun R, Wei H, Dong Z, Gao B, Tian Z. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. J Hepatol 2006; 44: 446-454.
178. Chen Y, Wei H, Sun R, Dong Z, Zhang J, Tian Z. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 2007; 46: 706-715.
179. Jinushi M, Takehara T, Tatsumi T, Yamaguchi S, Sakamori R, Hiramatsu N et al. Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4+ CD25+T cells with PD-1-dependent regulatory activities. Immunology 2007; 120: 73-82.
180. Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T et al. Negative regulation of NK cell activities by inhibitory receptor CD94/ NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 2004; 173: 6072-6081.
181. Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extraintestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 2006; 6: 244-251.
182. Henao-Mejia J, Elinav E, Thaiss CA, Licona-Limon P, Flavell RA. Role of the intestinal microbiome in liver disease. J Autoimmun 2013; 46: 66-73.
183. Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014; 146: 1513-1524.
184. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-185.
185. in C, Henao-Mejia J, Flavell RA. Innate immune receptors: key regulators of metabolic disease progression. Cell Metab 2013; 17: 873-882.
186. Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA. Inflammasomes and metabolic disease. Annu Rev Physiol 2014; 76: 57-78.
187. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54: 374-385.
188. Trivedi PJ, Chapman RW. PSC, AIH and overlap syndrome in inflammatory bowel disease. Clin Res Hepatol Gastroenterol 2012; 36: 420-436.
189. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13: 1324-1332.
190. Wang B, Trippler M, Pei R, Lu M, Broering R, Gerken G et al. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J Hepatol 2009; 51: 1037-1045.
191. Trivedi PJ, Adams DH. Mucosal immunity in liver autoimmunity: a comprehensive review. J Autoimmun 2013; 46: 97-111.
192. Oo YH, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 2010; 34: 45-54.
193. Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 2009; 157: 261-270.
194. Zhao L, Qiu de K, Ma X. Th17 cells: the emerging reciprocal partner of regulatory T cells in the liver. J Dig Dis 2010; 11: 126-133.
195. Katt J, Schwinge D, Schoknecht T, Quaas A, Sobottka I, Burandt E et al. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis. Hepatology 2013; 58: 1084-1093.
196. Zhao L, Tang Y, You Z, Wang Q, Liang S, Han X et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One 2011; 6: e18909.
197. Powell N, Walker AW, Stolarczyk E, Canavan JB, Gokmen MR, Marks E et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 2012; 37: 674-684.
198. Huber S, Gagliani N, Esplugues E, O'Connor Jr W, Huber FJ, Chaudhry A et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 2011; 34: 554-565.
199. Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006; 176: 4484-4491.
200. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49-63.
201. Bertolino P, Trescol-Biémont M-C, Thomas J, de St Groth BF, Pihlgren M, Marvel J et al. Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol 1999; 11: 1225-1237.